当前位置: X-MOL 学术Clin. Colorectal Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Survivorship in Early-Stage Rectal Cancer Patients Who Have Received Combined Modality Therapy
Clinical Colorectal Cancer ( IF 3.4 ) Pub Date : 2023-08-06 , DOI: 10.1016/j.clcc.2023.08.002
Saboor E Randhawa 1 , Laura Tenner 2
Affiliation  

Survival rates in early-stage rectal cancer patients have increased over the past few decades. Societies such as the National Comprehensive Cancer Network (NCCN), American Cancer Society (ACS), American Society of Clinical Oncology (ASCO), and European Society of Medical Oncology (ESMO) have proposed guidelines related to cancer survivorship care including formal recommendations to address the needs in early-stage rectal cancer survivors. These guidelines, in addition to new clinical research findings in survivorship will be reviewed, specifically looking at physical, psychosocial, and financial concerns in rectal cancer survivorship.



中文翻译:

接受联合治疗的早期直肠癌患者的生存率

在过去的几十年里,早期直肠癌患者的生存率有所提高。美国国家综合癌症网络 (NCCN)、美国癌症协会 (ACS)、美国临床肿瘤学会 (ASCO) 和欧洲肿瘤内科学会 (ESMO) 等协会提出了与癌症生存护理相关的指南,包括解决以下问题的正式建议:早期直肠癌幸存者的需求。除了关于生存的新的临床研究结果之外,这些指南也将得到审查,特别关注直肠癌生存的身体、社会心理和财务问题。

更新日期:2023-08-06
down
wechat
bug